Skip to content
Carian
NADA Profile
Corporate Info
Message from The Director General of National Anti-Drugs Agency (NADA)
Top Management
About NADA
Chief Digital Officer (CDO)
History Of NADA
Vision, Mission and Objectives
Client’s Charter
NADA Services
Client’s Charter Achievement Report
Policies, Acts & Circulars
Drugs-Related Legislations
ICT Management Circulars and Policies
Anti-Drug Agency Training Policy (DLAADK)
AADK Disciplinary Management Guide
Organizational Anti-Corruption Plan (OACP) NADA 2021-2025
NADA Anti-Corruption Policy
Divisions And Units
Treatment, Medicational And Rehabilitation Division
Enforcement And Security Division
Management Service Division
Information Technology And Communication Division
Policy and International Relations Division
Legal Advisory Unit
Media And Corporate Communication Unit
Integrity Unit
National Anti-Drugs Policy Implementation Coordination Secretariat Unit (MGDN)
NADA Training Centre
Directory
Headquarter
NADA State Office
NADA District Office
Rehabilitation Centre
NADA Service Centre
Community House
Client Integration Centre (CIC)
Anti-Drugs Border Unit (UAS)
NADA Training Centre
Services
Treatment & Rehabilitation
Institution Based Treatment And Rehabilitation
Community Based Treatment And Rehabilitation
NADA’s Tele Hello
NADA Products
Prevention
Public Awareness and Anti-Drugs Campaigns
High Risk Areas Of Drugs Addiction
Drugs Free Family
Drug Free Educational Institutions
Drugs Free Workplace
Drugs Free Community
Enforcement
Complaints on Drug Problems (Portal i-CARI AADK)
Hotline Operations Center (PGH)
Compliance with the Person Under Surveillance
Public
General
Verification Record For Applying Nigerian Visa
Federal Government Gazette
List of Private Drugs Rehabilitation Centers
Complaints and Feedback
NADA Integrity Complaint
e-Participation Policy
Online Services
Application for Anti-Drugs SKUAD Membership
Application for Anti-Drugs Exhibition
e-DrugNews
Library of NADA
The Malaysian Anti-Drugs Journal
NADA Industrial Training Application
Media & Publishing
NADA TV
Drugs Statistics
Annual Reports
Integrity Lens
FAQ
FAQ : Enforcement And Security
FAQ : Pusat Pemulihan Penagihan Narkotik (PUSPEN)
FAQ : NADA Service Centre
FAQ : Community House
FAQ : Client Integration Centre (CIC)
FAQ : Private Drug Rehabilitation Centre (PPDP)
FAQ : Antidrugs SKUAD
NADA Staff
Staff Login
NADA Official Email
Carian
NADA Profile
Corporate Info
Message from The Director General of National Anti-Drugs Agency (NADA)
Top Management
About NADA
Chief Digital Officer (CDO)
History Of NADA
Vision, Mission and Objectives
Client’s Charter
NADA Services
Client’s Charter Achievement Report
Policies, Acts & Circulars
Drugs-Related Legislations
ICT Management Circulars and Policies
Anti-Drug Agency Training Policy (DLAADK)
AADK Disciplinary Management Guide
Organizational Anti-Corruption Plan (OACP) NADA 2021-2025
NADA Anti-Corruption Policy
Divisions And Units
Treatment, Medicational And Rehabilitation Division
Enforcement And Security Division
Management Service Division
Information Technology And Communication Division
Policy and International Relations Division
Legal Advisory Unit
Media And Corporate Communication Unit
Integrity Unit
National Anti-Drugs Policy Implementation Coordination Secretariat Unit (MGDN)
NADA Training Centre
Directory
Headquarter
NADA State Office
NADA District Office
Rehabilitation Centre
NADA Service Centre
Community House
Client Integration Centre (CIC)
Anti-Drugs Border Unit (UAS)
NADA Training Centre
Services
Treatment & Rehabilitation
Institution Based Treatment And Rehabilitation
Community Based Treatment And Rehabilitation
NADA’s Tele Hello
NADA Products
Prevention
Public Awareness and Anti-Drugs Campaigns
High Risk Areas Of Drugs Addiction
Drugs Free Family
Drug Free Educational Institutions
Drugs Free Workplace
Drugs Free Community
Enforcement
Complaints on Drug Problems (Portal i-CARI AADK)
Hotline Operations Center (PGH)
Compliance with the Person Under Surveillance
Public
General
Verification Record For Applying Nigerian Visa
Federal Government Gazette
List of Private Drugs Rehabilitation Centers
Complaints and Feedback
NADA Integrity Complaint
e-Participation Policy
Online Services
Application for Anti-Drugs SKUAD Membership
Application for Anti-Drugs Exhibition
e-DrugNews
Library of NADA
The Malaysian Anti-Drugs Journal
NADA Industrial Training Application
Media & Publishing
NADA TV
Drugs Statistics
Annual Reports
Integrity Lens
FAQ
FAQ : Enforcement And Security
FAQ : Pusat Pemulihan Penagihan Narkotik (PUSPEN)
FAQ : NADA Service Centre
FAQ : Community House
FAQ : Client Integration Centre (CIC)
FAQ : Private Drug Rehabilitation Centre (PPDP)
FAQ : Antidrugs SKUAD
NADA Staff
Staff Login
NADA Official Email
National Anti-Drugs Agency
>
Policies, Acts & Circular
>
Drugs-Related Act
>
Dangerous Drugs (Special Preventive Measures) Act 1985 [Act 316]
Dangerous Drugs (Special Preventive Measures) Act 1985 [Act 316]
POLICIES, ACTS & CIRCULARS
State Drugs Policy
Drugs-Related Act
ICT Management Circulars and Policies
Anti-Drug Agency Training Policy (DLAADK)
AADK Disciplinary Management Guide
NADA Anti-Corruption Policy
Organizational Anti-Corruption Plan (OACP) AADK 2020-2024
Statement of NADA Anti-Corruption Policy
State Drugs Policy
Drugs-Related Act
ICT Management Circulars and Policies
Anti-Drug Agency Training Policy (DLAADK)
AADK Disciplinary Management Guide
NADA Anti-Corruption Policy
Organizational Anti-Corruption Plan (OACP) AADK 2020-2024
Statement of NADA Anti-Corruption Policy
Accessibility Toolbar
Toggle the visibility of the Accessibility Toolbar
Contrast
Increase Text
Decrease Text
Readable Font
Mark Titles
Highlight Links & Buttons
Hai! Saya Aida. Boleh saya bantu?
AIDA
Online
Transcribing audio...
Listening...
